nivolumab,bevacizumab,ipilimumab,celecoxib
roche,bms
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'niche', '/ipi', 'nivo', '3509']
final clinical analysis of the niche study abstr. 3509 neoadjuvant nivo/ipi in msi and mss crc
orr (100%) and dfs impressive in msi crc
orr 29% in mss crc 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine